Loading...
NPI 1023539053 · Brooklyn, NY · Cardiology Technician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Rhythm Management Group Corp is a cardiology technician provider located in Brooklyn, New York. This profile covers 2 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Rhythm Management Group Corp |
| Address | 45 Main St Ste 816 |
| City | Brooklyn |
| State | NY |
| ZIP | 11201 |
| Taxonomy | Cardiology Technician |
| NPI Enumerated | June 29, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $5.3M |
| Medicaid | $594.9K |
This provider’s billing is heavily Medicare-weighted: Total Medicare revenue is $5.3M compared with Total Medicaid revenue of $594.9K, indicating Medicare is the dominant payer and the primary driver of the practice’s scale and cash flow. The gap suggests the organization operates predominantly in the Medicare remote-monitoring space rather than as a Medicaid-focused clinic.
Medicare revenue is extremely concentrated: the precomputed top 3 Medicare codes account for 100.0% of its Medicare revenue, led by G2066 (78.2%) and 93296 (21.8%). Both codes show very large claim volumes (G2066: 63.2K claims, $65 avg paid/claim; 93296: 54.5K claims, $21 avg paid/claim), which points to a narrow service mix where a small set of monitoring/technical CPT/HCPCS codes produce essentially all Medicare reimbursement.
The code mix and descriptions indicate the provider’s core service line is remote interrogation and technical review of implantable cardiovascular devices: G2066 and 93296 are device interrogation/technical-review services for implantable monitors, implying the operation is primarily technician-led remote device monitoring with routine receipt, review, and distribution of device data to physicians. High claim counts and low per-claim payments are consistent with a volume-driven technical monitoring business model.
On national competitive standing for its Medicare specialty services, the provider is a clear outlier: G2066 ranks #2 of 3385 providers nationally (100th percentile; extreme outlier) and 93296 ranks #3 of 4996 providers nationally (100th percentile; extreme outlier). These ranks indicate the provider is far above typical national volume for these remote-device monitoring codes and functions as a nationally dominant high-volume participant for those services.
Medicaid revenue is likewise concentrated but to a slightly lesser degree—top 3 Medicaid codes account for 90.8% of Medicaid revenue, primarily G2066 (56.1%), 93299 (25.4%), and 93296 (9.3%). Claim-level details (G2066: 7.5K claims, $44 avg paid/claim; 93299: 2.2K claims, $67 avg paid/claim; 93296: 7.8K claims, $7 avg paid/claim) show the same remote-monitoring emphasis in the Medicaid population, though at substantially lower aggregate dollars than Medicare.
Within New York Medicaid, the provider is a leading in-state participant for these device-monitoring codes: G2066 ranks #2 of 169 providers in-state (99th percentile; extreme outlier), 93299 ranks #3 of 98 providers in-state (98th percentile; extreme outlier), and 93296 ranks #2 of 143 providers in-state (99th percentile; extreme outlier). These positions indicate the provider is among the largest state-level operators for technical device-monitoring services.
Physician-evaluation codes appear in the Medicaid mix but represent a small share of revenue and more typical volumes: 93297 accounts for 5.0% of Medicaid revenue (3.3K claims, $9 avg paid/claim) and 93298 accounts for 4.2% (1.9K claims, $13 avg paid/claim), with ranks described as typical or unremarkable at the state level. This suggests the organization’s role is primarily the technical component of device monitoring rather than delivering a large volume of physician professional evaluation services.
The provider has an established presence: NPI enumerated 2017-06-29 (~9 years ago). Sustained, multi-year, high-volume billing concentrated in a narrow set of implantable cardiac device monitoring codes implies built operational capacity and processes dedicated to remote device interrogation and technical result distribution rather than a diverse ambulatory cardiology practice.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system,… | 63,180 | $70 | $4.1M |
| 93296 | The technician gathers data, for a period of up to 90 days, from a patient’s single, dual, multiple lead, or leadless pacemaker system or implantable defibrillator system by remotely accessing the… | 54,510 | $20 | $1.1M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 2 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system,… | 7,490 | $40 | $329.7K |
| 93299 | N/A | 2,230 | $70 | $149.5K |
| 93296 | The technician gathers data, for a period of up to 90 days, from a patient’s single, dual, multiple lead, or leadless pacemaker system or implantable defibrillator system by remotely accessing the… | 7,820 | $10 | $54.7K |
| 93297 | The provider, who is a physician or other qualified healthcare professional, evaluates the physiologic data from the implantable physiologic cardiovascular monitoring system during a period of up 30… | 3,290 | $10 | $29.6K |
| 93298 | The provider, who is a physician or other qualified healthcare professional, evaluates the data from a previously implanted subcutaneous cardiac rhythm monitor system via telemetric communication for… | 1,890 | $10 | $24.6K |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system,… | 2 | 170 | 300 | $50 | $49.1K |
| 93299 | N/A | 3 | 100 | 90 | $70 | $22.8K |
| 93298 | The provider, who is a physician or other qualified healthcare professional, evaluates the data from a previously implanted subcutaneous cardiac rhythm monitor system via telemetric communication for… | 19 | 190 | 270 | $20 | $12.7K |
| 93296 | The technician gathers data, for a period of up to 90 days, from a patient’s single, dual, multiple lead, or leadless pacemaker system or implantable defibrillator system by remotely accessing the… | 2 | 140 | 280 | $10 | $9.1K |
| 93297 | The provider, who is a physician or other qualified healthcare professional, evaluates the physiologic data from the implantable physiologic cardiovascular monitoring system during a period of up 30… | 4 | 110 | 230 | $10 | $8.3K |
Other providers in the same ZIP code as Rhythm Management Group Corp, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.